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to total knee arthroplasty (TKA) compared to those that do not.
However, no modelling using gait biomechanics has predicted pro-
gression to TKA (a clear endpoint that includes structure and symp-
tom aspects of progression), and structural progression prediction
models only included individual frontal plane features. This study
determined: i) how well individual three-dimensional (3D) lower
limb biomechanical gait features discriminated between those who
progress to TKA and those that do not, ii) if a multivariate model
improved discrimination ability, and iii) how well gait biomechanical
features that best discriminated between groups predicted pro-
gression to TKA.
Methods: 54 knee OA patients underwent baseline gait analysis
where 3D lower limb motion and ground reaction forces were
recorded. 3D hip, knee, and ankle angles were expressed in the joint
coordinate system. External moments were calculated using inverse
dynamics and amplitude-normalized to body mass (Nm/kg). Wave-
form shape and magnitude features were extracted using Principal
Component Analysis (PCA), and waveforms were scored based on
how closely they matched an extracted pattern. PC scores were used
in statistical testing. Knee adduction moment (KAM) peak (Nm/kg)
and impulse (Nm/kg*s) were also calculated. 5-8 years later, 26
patients reported having TKA. Receiver operating characteristic
(ROC) curve analysis determined discriminative abilities of individual
gait variables. Stepwise discrimination analysis determined which
multivariate combinations discriminated between groups. Discrim-
inant function scores were calculated based on multivariate models,
and used as input for additional ROC curve analyses to determine
which multivariate model best discriminated between groups
(highest area under ROC curve). Logistic regression analysis deter-
mined predictive ability of the multivariate model with the highest
discrimination.
Results: There were no signiﬁcant baseline differences in demographic,
clinical and spatiotemporal gait characteristics, but 3D hip, knee, and
ankle gait features signiﬁcantly discriminated between TKA and no-TKA
groups. KAM impulse resulted in the best univariate discrimination
based on area under the ROC curve (AUC¼0.79) with overall shape and
magnitude of KAM (KAMPC1) having the second-highest AUC. Multi-
variate models had higher AUCs ranging from 0.80-0.85. In all multi-
variate models, overall KAM magnitude (impulse or KAMPC1) was the
most dominant variable for progression to TKA. The multivariate model
with the highest discrimination and correct classiﬁcation ability
(AUC¼0.85, 74.1% correct classiﬁcation rate) contained KAMPC1, dif-
ference between the early stance knee ﬂexion and late stance knee
extension moments (KFMPC2), and stance ankle dorsiﬂexion moment
(AFMPC4). Higher overall KAM magnitude, decreased knee ﬂexion to
extension moment difference, and decreased stance dorsiﬂexion
moment were associated with progression to TKA. This model had an
odds ratio of 5.7.
Conclusions: Non-frontal plane moments were predictive of pro-
gression to TKA. Multivariate models were better able to discriminate
between groups than univariate models, with the best model capturing
overall magnitude of loading (KAMPC1), and inability to unload the
knee (KFMPC2, AFMPC4). This suggests that higher overall cartilage
loading along with sustained cartilage loading were predictive of pro-
gression to TKA. These ﬁndings are consistent with animal models
showing that sustained loading can lead to cartilage degradation and
upregulation of inﬂammatory chemicals linked to knee pain. Sustained
cartilage loading has not previously been identiﬁed as a risk factor for
progression, and can be a new target in the development and evaluation
of conservative interventions.
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ESTABLISHMENT OF REFERENCE INTERVALS FOR OSTEOARTHRITIS
RELATED BIOMARKERS – THE FNIH/OARSI OA BIOMARKERS
CONSORTIUM
V. Byers Kraus y, D.E. Hargrove z, D.J. Hunter x, J.B. Renner k,
J.M. Jordan k. yDuke Univ., Durham, NC, USA; z LabCorp Clinical Trials, San
Leandro, CA, USA; xUniv. of Sydney, Sydney, Australia; kUniv. of North
Carolina, Chapel Hill, NC, USA
Purpose: A Reference Interval (RI) is the central 95% range - or normal
range - for endogenous analytes of a healthy person. Traditionally,
reference ranges for biomarkers are established using commercially
purchased "normals" including "normal" blood donors. Such "normals"are rarely adequate controls for Osteoarthritis (OA) studies as they are
rarely if ever ascertained for OA status. The objective of this ancillary
study was to establish reference intervals for the FNIH/OARSI panel of
OA related biochemical biomarkers using biospecimens from strin-
gently phenotyped age appropriate controls. We hypothesized that the
reference interval ranges for these ’super controls’ will facilitate future
formal FDA qualiﬁcation of the FNIH/OARSI OA-related biomarker panel
for OA diagnosis and prognosis and for monitoring the efﬁcacy of
intervention.
Methods: African-American (AA) and Caucasian (C) participants
were selected from the Johnston County Osteoarthritis Project (JoCo
OA) population-based study of OA. From among 1518 participants
with biospecimens and up to 15-years of follow-up radiographic
data, and 412 with biospecimens and radiographic data at one
timepoint, participants were selected who had no radiographic evi-
dence of knee OA (Kellgren-Lawrence [KL] 0 in each knee) or hip OA
(KL 0 or 1 in each hip), and no knee or hip symptoms (pain, aching or
stiffness on most days). Controls further had no radiographic hand
OA (GOGO deﬁnition) or spine radiographic OA (disc narrowing ¼ 0
and anterior osteophytes no greater than 1 at same level). This
yielded a total of N¼129 healthy ’super control’ participants with
minimal or no radiographic burden of disease, two-thirds of whom
had not developed OA in 15 years of observation. Baseline serum and
urine samples from these individuals were analysed in duplicate for
the analytes listed in Table 1. The RIs were determined with the
reference intervals establishment module of EP Evaluator (Data
Innovations) using transformed parametric calculations (Box-Cox
transformation), which transforms the data into a Gaussian model.
The SD ratio (cut-off >1.5) of the EP Evaluator partitioning test was
used to determine if separate reference intervals might be justiﬁed
for population subclasses based on gender or ethnicity (SD ratio
calculated as the larger SD divided by smaller SD of the two sub-
groups, male vs female and AA vs C). Spearman correlations were
used to assess for a correlation between the biomarker concen-
trations and age and body mass index (BMI).
Results: The sample of 129 super controls consisted of 64% women, 34%
African Americans, mean age 59 (SD 8.3, range 45-95) years, mean BMI
29 (SD 5.9) kg/m2. There were no out of range high values. Out of range
low values were set at just below the lower limit of detection of the
assay to compute the RI. The central 95% intervals for the 18 OA-related
biomarkers are provided in Table 1. Based on SD ratio >1.5, separate
reference intervals may be warranted on the basis of gender for sHA,
sMMP-3, sCol2-1NO2, uCTXIb/Cr, uCTXII/Cr, uNTXI/Cr, uCol2-1NO2/Cr
and on the basis of race for sCS846, sCOMP, sMMP3, sCTXI, sCPII, uCTXII/
Cr, and uCol2-1No2/Cr.
Conclusions: The ability to diagnose and prognose OAwith biomarkers
is dependent on a clear understanding of normal reference intervals. For
a highly prevalent and heterogeneous disorder such as OA, the lack of
ascertainment of OA status leads to misclassiﬁcation of controls. These
well-phenotyped controls represent a similar age demographic to that
of the Osteoarthritis Initiative-FNIH main study sample so they should
provide an optimal reference control for the main study. To our
knowledge, no comparable ’super control’ sample has ever been char-
acterized for such an extensive panel of OA-related biomarkers.
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LIPIDS AS MEDIATORS OF CHONDROGENESIS
N. Georgi y, B. Cillero Pastor z, G. Eijkel z, P.C. Periyasamy y, A. Kiss x,
C. van Blitterswijk y, J.N. Post y, R. Heeren z, M. Karperien y. yMIRA Inst.
for BioMed. technology and technical medicine, Enschede, Netherlands;
z FOM Inst. AMOLF, Amsterdam, Netherlands; x FOM Inst. AMOLF,
Amsterdam, Netherlands
Purpose: We have previously demonstrated that cartilage matrix for-
mation is improved in pellet co-cultures of human mesenchymal stro-
mal/stem cells (MSCs) and human primary chondrocytes (hPCs) under
normoxic culture conditions (21%O2). This co-culture effect is attributed
to the MSC speciﬁc expression of FGF-1. Under hypoxic culture con-
ditions (2.5%O2),weobserved that therewas adecrease in chondrogenic
differentiation in co-cultures as compared to the normoxic culturing
conditions. For clinical applications it is plausible that co-transplantation
of MSCs and chondrocytes into the defect results in improved cartilage
repair. Until now it remains unclear how FGF-1 expression is regulated
under the reduced oxygen level normally present in the joint. It has been
underlined that hypoxia (reduced oxygen availability) and expression of
Table 1
Reference Interval (RI) estimations, N¼129 (serum concentrations reported in ng/ml except serum Col2-1 NO2 in nM); urine concentrations normalized to urinary Cr and
reported in the units indicated)
Biomarker Manufacturer Mean (SD) Central 95% Interval Conﬁdence Ratio Signiﬁcant Spearman Correlations
r (p value]
MIN MAX AGE/BMI
Serum COMP Biovendor 1016.12 (650.19) 404 2070 0.15 None
Serum HA Corgenix 55.08 (21.41) 34 83 0.13 r 0.28 (0.001) with age
Serum CPII IBEX 1450.90 (401.08) 830 2362 0.14 None
Serum CS846 IBEX 112.90 (29.83) 74 164 0.13 None
Serum MMP-3 Invitrogen 16.86 (16.15) 3.32 50.94 0.20 None
Serum PIIANP EMD Millipore 2879.90 (705.58) 1690 4431 0.13 r 0.27 (0.002) with age
Serum C1,2C IBEX 407.13 (107.43) 228 646 0.13 None
Serum C2C IBEX 278.23 (48.98) 196 383 0.13 None
Serum NTXI Ostermark/ Alere 16.02 (5.06) 9 27 0.14 None
Serum CTXI IDS 0.31 (0.22) 0.093 0.741 0.17 None
Serum Col2-1 NO2 Artialis 9.01 (4.42) 3.24 20.20 0.16 None
Urinary CTXII (ng/mmol Cr) IDS 293.50 (521.23) 59.80 765.21 0.19 None
Urine NTXI (nmol BCE/mmol Cr) Ostermark/ Alere 36.93 (21.37) 11 90 0.17 None
Urine (alpha) CTXI (mg/mmol Cr) IDS 0.67 (0.58) 0.13 1.98 0.20 r -0.17 (0.052) with BMI
Urine (beta) CTXI (mg/mmol Cr) IDS 2.54 (1.87) 0.49 8.06 0.20 None
Urine C2C (HUSA) (mg/mmol Cr) IBEX 108.97 (62.09) 36 258 0.17 None
Urine C1,2C (ng/mmol Cr) IBEX 0.017 (0.010) 0.0 0.04 0.14 None
Urine Col2-1 NO2 (nmol/mmol Cr) Artialis 0.032 (0.022) 0.0087 0.0831 0.18 None
COMP¼cartilage oligomeric matrix protein; HA¼Hyaluronan; CPII¼type II collagen carboxy propeptide cleaved following release of newly synthesized procollagen into
matrix; CS846¼chondroitin sulphate epitope of aggrecan; MMP-3¼Matrix Metalloproteinase-3 also called stromelysin-1; PIIANP¼N-propeptide encoded by exon 2 of type II
collagen; C1,2C¼C-terminal neoepitoe of ¾ piece generated by cleavage of types I and II collagen by collagenases; C2C¼C-terminal neoepitoe of ¾ piece generated by cleavage
of type II collagen by collagenases; NTXI¼N-terminal telopeptide of type I collagen; CTXI¼C-terminal telopeptide of type I collagen (also called CrossLaps), alpha CTXI contains
the newly synthesized alpha form of aspartic acid, beta CTXI contains the age-related beta form of aspartic acid; Col2-1 NO2 ; CTXIl¼C-terminal telopeptide of type II collagen
(also called CartiLaps); Cr¼creatinine.
All urinary biomarkers are normalized to mmol/L urinary creatinine (Quidel).
Conﬁdence Ratio is the average conﬁdence interval width to the reference interval width; a value of 0.10 or less is desirable, values < 0.30 are considered acceptable.
Signiﬁcant Spearman Correlations are deﬁned as p<0.05.
BCE¼bone collagen equivalents.
Figure 1. Top panel: Sections of pellets stained with Oil Red O for lipids.
Bottom panel: Quantiﬁcation of Oil Red O intensity (left), Quantiﬁcation of
Total cholesterol inpellets (middle), Quantiﬁcation of Phospholipids (right).
Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S47hypoxia-inducible factor 1 (HIF-1) are essential in maintaining cartilage
homeostasis. Moreover, it has been shown that primary chondrocytes
perform better under reduced oxygen levels. However, only limited
research has been performed to understand how hypoxia in the joint
environment might inﬂuence cellular performance. Differential
expression of proteins, lipids and other components indicate the unique
behaviour of cells under different environmental conditions. In this
study we aimed to identify the mechanism leading to the loss of co-
culture effect under hypoxic conditions.
Methods: We used Time-of-ﬂight secondary ion mass spectrometry
(TOF-SIMS) to study the presence of lipids in chondrocytes, MSCs and
Chondrocyte/ MSC co-cultures under normoxia and hypoxia. We per-
formed biochemical assays to capture overall lipid expression, quanti-
ﬁcation of total cholesterol and phospholipids. Alcian blue staining was
used to visualize sulfated GAG deposition. qPCR was used to identify the
modulation of FGF-1 and of chondrogenic markers such as SOX9 and
COL2a1.
Results: TOF-SIMS data revealed that normoxia allows for a rich pres-
ence of lipids in co- and mono-culture of hMSCs and hPCs. The highest
amount of lipids was found in chondrocytes. Under hypoxia the overall
lipid content was signiﬁcantly decreased. Oil Red O staining supported
the TOF-SIMS data (ﬁgure 1). Principle component analysis (PCA)
showed that speciﬁcally cholesterol and diacylglycerols were found to
be more abundant under normoxia. Our biochemical analysis for cho-
lesterol and phospholipids support these data. Under normoxic con-
ditions GAG deposition was increased and the morphology of the
matrix more resembled that of articular cartilage, when compared to
hypoxic co-cultures. This was veriﬁed by a higher SOX9 mRNA
expression in normoxic co-cultures.
We correlated the presence of lipids to the FGF-1 mRNA expression.
Under normoxic conditions an increase in FGF-1 production was
observed in co-cultures. This was accompanied by better chondro-
genesis as compared to chondrogenesis in hypoxic co-cultures. When
we blocked the availability of free cholesterol in cells under normoxic
conditions, we found that the FGF-1 expressionwas negatively affected,
indicating that cholesterol can directly regulate FGF-1mRNA expression
(ﬁgure 2).
Conclusions: We found that FGF-1 expression was dependent on
rich lipid content in the cultures and that speciﬁcally cholesterol hada modulatory role. We conclude that higher cholesterol under nor-
moxia might be responsible for the improved performance of co-
cultured pellets by regulating FGF-1 gene expression. These ﬁndings
facilitate a better understanding of mechanistic routes in in vitro co-
cultures of MSCs and hPCs. Furthermore, our data indicate that a
cell’s lipid composition is dependent on oxygen exposure and that
these changes in lipids either directly or indirectly inﬂuence chon-
drogenesis.
Figure 2. Relative expression of FGF1 mRNA under different culture
conditions in co- and mono-cultures of hMSCs and hPCs.
Note: the ﬁrst two authors contributed equally to this work.
Figure 1. A rug-plot of bivariate scatters of ARGS-aggrecan concentrations
in SF, serum, plasma and urine from 36 subjects at different times over 5
years after ACL injury. Concentrations in urine are given corrected for
urinary creatinine. Filled circles are concentrations measured within the
detection limits of the ARGS-aggrecan assay. Open circles are urinary
ARGS concentration below the assay Lower Limit Of Quantiﬁcation (LLOQ;
0.025 pmol/ml) that were imputed to half the LLOQ value. Linear
regression lines (solid) with 95% conﬁdence intervals (long dashed) are
indicted in each scatter plot. In the rug-plot, each bivariate scatter plot
shares information of one variate with the adjacent plot, illustrated by
interconnecting rug fringes showing the marginal distribution of the
shared variate. Horizontal and vertical lines (short dashed) interconnect
ARGS concentrations in different bivariate combinations of ﬂuids in one
subject. All scales are logarithmic and reﬂect the range of ARGS concen-
trations in each ﬂuid.
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ARGS-AGGRECAN QUANTIFICATION IN SYNOVIAL FLUID, SERUM,
PLASMA AND URINE - AN ASSAY VALIDATION
S. Larsson y, S. Lohmander y,z, A. Struglics y. yDept. of Orthopaedics,
Clinical Sci. Lund, Lund Univ., Lund, Sweden; zRes. Unit for
Musculoskeletal Function and Physiotherapy, and Dept. of Orthopaedics
and Traumatology, Univ. of Southern Denmark, Odense, Denmark
Purpose: Aggrecanase cleavage at the 392Glu-393Ala bond in the
interglobular domain of aggrecan, releasing N-terminal 393ARGS
fragments into synovial ﬂuid (SF), is an early key event in arthritis
and joint injuries. We have shown that SF-ARGS is associated with
radiographic progression of knee osteoarthritis (OA) as well as with
progression of self-reported pain after meniscectomy. Our objective
was to validate a modiﬁed ligand-binding assay for the detection of
aggrecanase generated aggrecan fragments with the ARGS neo-
epitope in SF, blood and urine, and to verify the identity of aggrecan
fragments found in blood.
Methods: A sandwich enzyme-linked immunosorbent assay (ELISA) on
the Meso Scale Discovery (MSD) platform for detection of ARGS-
aggrecanwas validated, using a standard made by ADAMTS-4-digestion
of recombinant human aggrecan (1220-PG, R&D Systems), an anti-
aggrecan antibody (AHP0022, Invitrogen) for capture, and amonoclonal
anti-ARGS (OA-1, GlaxoSmithKline) for detection. We analysed recovery
to dilution and spiking of equimolar concentrations of standard in SF
and serum samples. Matched samples of SF, serum, plasma, and urine
were obtained from 36 subjects at different time points 0 to 5 years
after an anterior cruciate ligament (ACL) tear, and analysed for ARGS-
aggrecan content. Aggrecan was puriﬁed by caesium chloride density
gradient centrifugation from serum and plasma pools and analysed by
Western blot using the anti-ARGS antibody. We used Spearman’s rank
order correlation (rS) for assessment of correlation, based on Shapiro-
Wilk test indicating skewed distributions of a majority of the variables.
Results: The limits of quantiﬁcation for the ARGS-aggrecan assay was
between 0.2 and 0.025 pmol ARGS/ml. Inside these limits recovery to
dilution was, mean (range) 100% (83-117%), and to spiking 89% (77-
110%). The sensitivity of the assay was improved 2-fold compared to
when using a standard puriﬁed from human donors. The ARGS con-
centrations were highest in SF (mean, range; 3.02, 0.36 - 30.22 pmol/
ml), 20 times lower in the blood samples (0.14, 0.055 - 0.28 pmol/ml
serum and 0.13, 0.053 - 0.28 pmol/ml plasma), and 80 times lower in
urine (0.036, <0.025 - 0.087 pmol/ml). Serum-ARGS and plasma-ARGS
concentrations were similar, and correlated (Figure 1: rS ¼ 0.773). SFconcentrations correlated with serum and plasma concentrations
(Figure 1: rS ¼ 0.420 and 0.386, respectively). In puriﬁed serum and
plasma samples, we identiﬁed 129-138 kDa aggrecan fragments con-
taining the ARGS neoepitope.Conclusions: This novel ARGS-aggrecan assay is highly sensitive and
suited for analysis of SF and blood samples. Both SF and blood contains
ARGS-aggrecan, and ARGS concentrations in SF and blood are correla-
ted.
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SPECIFIC PEPTIDE DISTRIBUTION IN HUMAN OSTEOARTHRITIC
SYNOVIAL MEMBRANES REVEALS DIFFERENT GRADES OF TISSUE
INFLAMMATION
B. Cillero-Pastor y, G. Eijkel y, F. Blanco z, R. Heeren y. yAMOLF-FOM Inst.,
Amsterdam, Netherlands; zRheumatology Div.. Proteomic Group. Proteo-
Red-ISCIII. INIBIC-Hosp. Univ.rio A Coru~na, A Coru~na, Spain
Purpose: The synovial membrane is an important source for biomarker
discovery of many rheumatic pathologies. The heterogeneity of osteo-
arthritis (OA) affected tissues and the spatial distribution of proteins in
the human synovial membrane is poorly studied. The speciﬁc protein
and peptide proﬁles in different areas of the synovial tissue can reveal
information about the underlying pathways that play a role in the OA
pathology. The distribution of these speciﬁc protein/peptide proﬁles
can be used for tissue/patient classiﬁcation. Matrix assisted laser
desorption ionization mass spectrometric imaging (MALDI-MSI) is a
novel technique that can be employed to reveal the molecular signature
of a region or area of interest in a biological tissue. In this work, we have
studied the peptide proﬁles and their distributions in human normal
and OA synovial membranes.We have described speciﬁc OA biomarkers
commonly found in cartilage and synovial tissues by MALDI-MSI.
